FindTrial
Sign In

A multicentre observational study of treatment compliance and care burden in patients with AD treated for the first time with Cabalatin

A multicentre observational study of treatment compliance and care burden in patients with AD treated for the first time with Cabalatin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044861
Enrollment
Unknown
Registered
2021-03-30
Start date
2021-04-15
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s Disease

Interventions

single arm:Null

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=50 years; 2. Diagnosed with Alzheimer's disease according to DSM-5 diagnostic criteria; 3. Carbalatin treatment was started within 1 month before enrollment; 4. CDR overall score < 3 points; 5. Subjects and guardians csigned informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, kidney and liver dysfunction; 2. With diseases that cause dementia, such as vascular dementia, central nervous system infection (such as AIDS, syphilis, etc.), Creutzfeldt-Jakob disease, Huntington's disease and Parkinson's disease, Hydrocephalus, brain tumors, endocrine diseases, severe anemia, etc.; 3. Patients currently participating in other clinical drug trials.

Design outcomes

Primary

MeasureTime frame
Medication compliance at 1 year follow-up;—

Countries

China

Contacts

Public ContactWang Huali

Peking University Sixth Hospital

huali_wang@bjmu.edu.cn+86 13601163971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026